Mini-Metrxics: a single-centre, randomized, double-blind, parallel-group, placebo-controlled, clinical trial of CMI X-11S in higher risk geriatric patients undergoing open-heart surgical procedures (OHSP)

Trial Profile

Mini-Metrxics: a single-centre, randomized, double-blind, parallel-group, placebo-controlled, clinical trial of CMI X-11S in higher risk geriatric patients undergoing open-heart surgical procedures (OHSP)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 11 Dec 2007

At a glance

  • Drugs CMI X 11S (Primary)
  • Indications Coronary disorders
  • Focus Therapeutic Use
  • Acronyms Mini-METR*ICS
  • Sponsors Valens Pharma
  • Most Recent Events

    • 11 Dec 2007 The enrolment midpoint has been reached, with 40 patients currently enrolled.
    • 13 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top